Stock LAVI LAVIPHARM S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Lavipharm S.A.

Equities

LAVI

GRS246003008

Delayed Athens S.E.
Other stock markets
 05:55:02 2024-04-29 am EDT 		5-day change 1st Jan Change
0.852 EUR -0.93% Intraday chart for Lavipharm S.A. +0.59% +7.04%
Feb. 28 Lavipharm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Lavipharm S.A. entered into a new asset purchase agreement to acquire Flagyl product line for Greek market from Sanofi. CI

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Neutral

Bullish

Bullish

Resistance 0.9500 0.9500 0.9400
Spread/Res.-9.47%-9.47%-8.51%
Spread/Supp.+11.11%+11.11%+41.91%
Support 0.7740 0.7740 0.6060
  1. Stock Market
  2. Equities
  3. LAVI Stock
  4. Charts Lavipharm S.A.